Furosemide-Associated Hyponatremia

Mechanism and Clinical Context

• Overzealous diuretic therapy with furosemide causes hypovolemic hyponatremia through prolonged negative sodium balance and marked extracellular fluid loss, requiring plasma volume expansion with normal saline and cessation of diuretics in patients with significant volume depletion 1
• The European Association for the Study of the Liver recommends reducing or discontinuing diuretics when serum sodium falls below 125 mmol/L in cirrhotic patients to prevent further hyponatremia development 2

Combination Therapy Risks

• The addition of furosemide to other diuretics, particularly thiazides like hydrochlorothiazide, increases the risk of rapid hyponatremia development, as documented in patients with advanced liver disease 3, 4

Population-Specific Considerations

Cirrhosis with Ascites

• Hyponatremia occurs in 8-30% of hospitalized cirrhotic patients treated with diuretics, related to impaired free water excretion, and guidelines recommend temporarily discontinuing diuretics when sodium drops below 125 mmol/L, according to the European Association for the Study of the Liver 5, 6, 1
• The American Association for the Study of Liver Diseases suggests reducing or stopping loop diuretics preferentially over aldosterone antagonists in cirrhotic patients with hyponatremia to minimize further volume depletion 2